Oct 22, 2019
IA, Iowa, Iowa Laboratory Facility, Iowa Medical Cannabidiol Advisory Board, low-THC cannabis, low-THC medical cannabis program, medical cannabis, Medical Marijuana, meeting, patients, post traumatic stress disorder, PTSD, qualifying condition
On Friday, November 1, the Iowa Medical Cannabidiol Advisory Board will decide whether to add PTSD as a qualifying condition under the state's low-THC medical cannabis program.
If you are a patient suffering from PTSD or a supportive medical professional, don't miss this opportunity to voice your support. You can find more information on PTSD and medical cannabis programs here.
If you can't attend the meeting, or if you want to send comments in writing, you can email your comments to the Board at email@example.com in advance of the meeting.
You can also attend the meeting in person. The public will have the opportunity to comment at the start of the meeting.
When: Friday, November 1, 10:00 a.m. – 12:30 p.m.
Where: Iowa Laboratory Facility – 2240 DMACC Blvd, Ankeny, IA 50023
Please also write your lawmakers and ask them to support a comprehensive medical marijuana program. Unfortunately, by limiting patients to low-THC cannabis, Iowa's current program is leaving the vast majority of those who could benefit from medical cannabis behind.
Together, we can help Iowa patients access the medicine they deserve.